Jupiter Fund Management Plc (JUP)
London Exchange · UK · prices in GBX · close of 23 Oct 2026
Key indicators
| Last close | GBX 170.00 |
|---|---|
| 52-week range | 137.20 – 214.50 |
| Return, 1 month / 3 months | +2.9% / +11.5% |
| Return, 1 year / 3 years | +22.5% / +161.4% |
| Trend | Uptrend |
| RSI (14) | 50 |
| Volatility (1 year) | 29.3% |
| Worst drawdown (1 year) | -19.4% |
| Average daily value traded | 302.06M GBX |
| Dividend yield | 6.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Jupiter Fund Management is a British asset management company based in London. It manages investment funds on behalf of individual savers and institutional clients, offering strategies across equities, fixed income and multi-asset portfolios. Its fund managers run a range of portfolios focused on UK and European markets as well as other regions, and the company distributes its funds through financial advisers and platforms. Jupiter earns revenue from the fees it charges for managing these investments.
Jupiter Fund Management Plc trades under the code JUP on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Jupiter Fund Management Plc (JUP) trades on the London Exchange in UK. It last closed at GBX 170.00 on 23 October 2026.
Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 478 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 22.5% and over the last three months it rose 11.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 59 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.6% | ||
| From 52-week high | -12.9% | ||
| Momentum | 74 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 11.5% | ||
| 6-month return | 11.6% | ||
| 12-month return, skipping the last month | 19.0% | ||
| Stability (higher is calmer) | 69 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 29.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.4% | ||
| Liquidity | 94 · Strong | Trades actively. | |
| Average daily value traded | 302.06M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 64 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 6.9% | ||
| Years with dividends | 5 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −3.3% |
|---|---|
| 1 month | +2.9% |
| 3 months | +11.5% |
| 6 months | +11.6% |
| 1 year | +22.5% |
| 3 years | +161.4% |
| 5 years | −0.2% |
Signals
| 50-day / 200-day average | 166.90 / 164.11 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.19 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Aug 2026 | GBP 0.0370 |
| 16 Apr 2026 | GBP 0.0800 |
| 7 Aug 2025 | GBP 0.0210 |
| 17 Apr 2025 | GBP 0.0220 |
| 8 Aug 2024 | GBP 0.0320 |
| 18 Apr 2024 | GBP 0.0340 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.